X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs DR. REDDYS LAB - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES DR. REDDYS LAB PIRAMAL ENTERPRISES/
DR. REDDYS LAB
 
P/E (TTM) x 37.1 28.6 129.6% View Chart
P/BV x 3.7 2.9 125.4% View Chart
Dividend Yield % 0.7 1.0 68.5%  

Financials

 PIRAMAL ENTERPRISES   DR. REDDYS LAB
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
DR. REDDYS LAB
Mar-16
PIRAMAL ENTERPRISES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,0654,383 24.3%   
Low Rs8052,750 29.3%   
Sales per share (Unadj.) Rs383.0920.1 41.6%  
Earnings per share (Unadj.) Rs55.1126.1 43.7%  
Cash flow per share (Unadj.) Rs74.1183.0 40.5%  
Dividends per share (Unadj.) Rs17.5020.00 87.5%  
Dividend yield (eoy) %1.90.6 333.8%  
Book value per share (Unadj.) Rs719.9685.8 105.0%  
Shares outstanding (eoy) m172.56170.61 101.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.43.9 63.0%   
Avg P/E ratio x17.028.3 60.0%  
P/CF ratio (eoy) x12.619.5 64.8%  
Price / Book Value ratio x1.35.2 25.0%  
Dividend payout %31.815.9 200.3%   
Avg Mkt Cap Rs m161,344608,481 26.5%   
No. of employees `0003.821.7 17.5%   
Total wages/salary Rs m16,89831,874 53.0%   
Avg. sales/employee Rs Th17,472.67,244.4 241.2%   
Avg. wages/employee Rs Th4,466.91,470.9 303.7%   
Avg. net profit/employee Rs Th2,512.8992.8 253.1%   
INCOME DATA
Net Sales Rs m66,099156,978 42.1%  
Other income Rs m2,4252,693 90.0%   
Total revenues Rs m68,524159,671 42.9%   
Gross profit Rs m18,72334,587 54.1%  
Depreciation Rs m3,2749,705 33.7%   
Interest Rs m9,388824 1,139.3%   
Profit before tax Rs m8,48526,751 31.7%   
Minority Interest Rs m30-   
Prior Period Items Rs m1,5930-   
Extraordinary Inc (Exp) Rs m4570-   
Tax Rs m1,0325,237 19.7%   
Profit after tax Rs m9,50621,514 44.2%  
Gross profit margin %28.322.0 128.6%  
Effective tax rate %12.219.6 62.1%   
Net profit margin %14.413.7 104.9%  
BALANCE SHEET DATA
Current assets Rs m47,488118,201 40.2%   
Current liabilities Rs m104,36268,368 152.6%   
Net working cap to sales %-86.031.7 -271.0%  
Current ratio x0.51.7 26.3%  
Inventory Days Days4160 67.7%  
Debtors Days Days5197 52.8%  
Net fixed assets Rs m26,53272,265 36.7%   
Share capital Rs m345853 40.5%   
"Free" reserves Rs m114,024111,548 102.2%   
Net worth Rs m124,221117,009 106.2%   
Long term debt Rs m75,81210,690 709.2%   
Total assets Rs m308,356200,104 154.1%  
Interest coverage x1.933.5 5.7%   
Debt to equity ratio x0.60.1 668.0%  
Sales to assets ratio x0.20.8 27.3%   
Return on assets %6.111.2 54.9%  
Return on equity %7.718.4 41.6%  
Return on capital %10.021.6 46.1%  
Exports to sales %17.246.3 37.2%   
Imports to sales %6.69.0 73.8%   
Exports (fob) Rs m11,36272,618 15.6%   
Imports (cif) Rs m4,36414,050 31.1%   
Fx inflow Rs m14,43575,405 19.1%   
Fx outflow Rs m5,18327,115 19.1%   
Net fx Rs m9,25348,290 19.2%   
CASH FLOW
From Operations Rs m-67,77340,476 -167.4%  
From Investments Rs m-8,768-19,421 45.1%  
From Financial Activity Rs m76,199-17,009 -448.0%  
Net Cashflow Rs m-3424,046 -8.5%  

Share Holding

Indian Promoters % 52.9 25.5 207.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 5.4 74.1%  
FIIs % 26.6 35.3 75.4%  
ADR/GDR % 0.0 18.5 -  
Free float % 16.5 15.3 107.8%  
Shareholders   93,274 75,885 122.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   J.B.CHEMICALS  ALEMBIC LTD  STERLING BIOTECH  CADILA HEALTHCARE  SUVEN LIFE  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Flat Finish to the Week; Cadila Healthcare Rallies 7%(Closing)

Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks, software stocks and capital good stocks.

Related Views on News

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - FDC LTD. COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS